A low-molecular-weight chemical inducer of interferon, 10-carboxymethyl-9-acridanone (CMA), effectively prevented death caused by Japanese encephalitis virus (JEV) injected peripherally into weanling mice and baby hamsters. Marked reductions in mortality were seen in mice when a single dose of CMA was administered intraperitoneally, subcutaneously, or intramuscularly to animals challenged intraperitoneally with JEV. The degree of protection was dependent on dose and time of administration of CMA in relation to virus challenge: all hamsters given CMA on the same day as JEV survived, with lesser although still significant protection when CMA was given one or two days after JEV. Viremia, an important characteristic of the pathogenesis of natural JEV infection, was reduced nearly 10,000-fold in hamsters treated with CMA. Thus, in the experimental animal models developed for these studies, CMA provided marked therapeutic and prophylactic effect against JEV.

10-Carboxymethyl-9-acridanone (CMA) was shown to be a very potent interferon inducer in young and old Swiss albino as well as congenitally asplenic mice. This compound (molecular weight, 275) induced titers of interferon in plasma comparable to those obtained with the best viral inducers, attaining > 400,000 U/ml in mice in 2 to 3 h. CMA concentrations were highest in mouse plasma 1 h after intraperitoneal or oral delivery. Induction was dose dependent over a wide range. Intraperitoneal, subcutaneous, or intramuscular injections of CMA gave comparable ranges of interferon titers. Oral delivery by gavage gave lower titers (65,000 U/ml), but higher than those reported with other low-molecular-weight interferon inducers in mice. CMA injected into week-old hamsters (which usually produce iterferon poorly) induced levels of interferon as high as 6,400 U per ml of plasma in a dose-dependent fashion, but kinetics of interferon induction was less rapid than in mice. The mouse and hamster interferons induced by CMA had physical characteristics similar to those of virus-induced interferons of the homologous species. The unusually high yields of interferon obtainable with this chemical inducer suggest its use for further experimental antiviral or antitumor therapy.

The attenuated American BT-8 strain of bluetongue virus is 5 to 10 times more potent an interferon inducer than any other viral or nonviral agent reported to date, including as much as 600,000 units/ml of plasma by 8 h after intravenous injection.

No abstract